by Super Admin - 6 hours ago
- $30 Million Registered Direct Offering Support Next Stage of Development for Zervimesine (CT1812) -
by Super Admin - 6 hours ago
Leptomeningeal metastases disease session features novel treatments in the horizon, REYOBIQ™ and ReSPECT-LM, and future directions and needs Leptomeningeal metastases disease session features novel treatments in the horizon, REYOBIQ™ and ReSPECT-LM,...
by Super Admin - 6 hours ago
WAYNE, Pa., Nov. 06, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: PVLA) Palvella Therapeutics, Inc. (Palvella or “the Company”), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering f...
by Super Admin - 6 hours ago
Leading Boston-based bank focused on outstanding client experience unifies multiple legacy systems onto nCino’s comprehensive platform Leading Boston-based bank focused on outstanding client experience unifies multiple legacy systems onto nCino’s com...
by Super Admin - 6 hours ago
Solo Brands Accelerates Structural Cost Reduction to Match Current Demand Levels; Delivers $11 Million of Operating Cash in Q3, Marking Second Consecutive Quarter of Positive Cash Flow Solo Brands Accelerates Structural Cost Reduction to Match Curren...
by Super Admin - 6 hours ago
MasterCraft Boat Holdings, Inc. Reports Fiscal 2026 First Quarter Results
by Super Admin - 6 hours ago
Lexicon Pharmaceuticals reported third quarter 2025 financial results and provided an update on key corporate milestones and accomplishments.
by Super Admin - 6 hours ago
TROY, Mich., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Kelly (Nasdaq: KELYA, KELYB), a leading specialty talent solutions provider, today announced results for the third quarter of 2025.
by Super Admin - 6 hours ago
Achieved record-high quarterly revenues, Adjusted EBITDA1 and Adjusted EBITDA per share1 since inception Increased 2025 financial guidance
by Super Admin - 6 hours ago
Niveau record trimestriel de produits des activités ordinaires, de BAIIA ajusté1 et de BAIIA ajusté par action1 Prévisions financières révisées à la hausse pour 2025
by Super Admin - 6 hours ago
New data builds on prior results, highlights LTI-03's differentiated approach, and supports the ongoing global Phase 2 RENEW trial New data builds on prior results, highlights LTI-03's differentiated approach, and supports the ongoing global Phase 2...
by Super Admin - 6 hours ago
IND Submission for CR-001, a PD-1 x VEGF Bispecific Antibody, on Track for Fourth Quarter of 2025 to Support Initiation of Global Phase 1 Trial in Patients with Solid Tumors
by Super Admin - 6 hours ago
- NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES - - NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES -
by Super Admin - 6 hours ago
PITTSBURGH, Nov. 6, 2025 /PRNewswire/ -- "I wanted to create a new tombstone that can be personalized to share a hobby, interest, or other important aspect from the departed loved one's life," said an inventor, from Allen Park, Mich., "so I invented...
by Super Admin - 6 hours ago
Representatives from Cummins, Cyclic Materials, Magna, and NTIC / Zerust recognized for environmental leadership SALINE, Mich., Nov. 6, 2025 /PRNewswire/ -- The Suppliers Partnership for the Environment (SP), an association of global vehicle manufact...